Get started
10X GENOMICS INC COM USD0.00001 CLASS A10X GENOMICS INC COM USD0.00001 CLASS A10X GENOMICS INC COM USD0.00001 CLASS A

10X GENOMICS INC COM USD0.00001 CLASS A

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals

0A88 trade ideas

TXG rounding bottomNASDAQ:TXG looks to have found a bottom. Looking for $150 soon then $158. SL at break of $134 support None of the content published constitutes a recommendation that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. Information provided in this correspondence is intended solely for informational purposes and is in no way guaranteed. For financial advise seek appropriate investment advice from a licensed Industry representative.
NASDAQ:TXGLong
by Mullamaker
TXG time to cool offTXG with a monstrous 30% move over 10 consecutive sessions. RSI needs to cool off and MACD divergence indicating momentum is slowing. None of the content published constitutes a recommendation that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. Information provided in this correspondence is intended solely for informational purposes and is in no way guaranteed.For financial advise seek appropriate investment advice from a licensed Industry representative.
NASDAQ:TXGShort
by Mullamaker
2
TXG, Aroon Indicator entered an Uptrend on Oct 19, 2020.Over the last three days, Tickeron A.I.dvisor has detected that TXG's AroonUp green line (see chart) is above 70, while the AroonDown red line is below 30. When the green line goes above 70 while the red line stays below 30, this is an indicator that the stock could be poised for a strong Uptrend. For traders, this could mean going long the stock or exploring call options in the next month. Tickeron A.I.dvisor backtested this indicator and found 92 similar cases, 86 of which were successful. Based on this data, the odds of success are 90%. Current price $152.96 is above $113.51 the highest resistance line found by Tickeron A.I. Throughout the month of 09/17/20 - 10/19/20, the price experienced a +36% Uptrend. During the week of 10/12/20 - 10/19/20, the stock enjoyed a +4% Uptrend growth. Bullish Trend Analysis The Momentum Indicator moved above the 0 level on September 28, 2020. You may want to consider a long position or call options on TXG as a result. Tickeron A.I. detected that in 14 of 16 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 88%. The Moving Average Convergence Divergence (MACD) for TXG just turned positive on October 02, 2020. Looking at past instances where TXG's MACD turned positive, the stock continued to rise, Tickeron A.I. shows that in 6 of 7 cases over the following month. The odds of a continued upward trend are 86%. The Aroon Indicator entered an Uptrend today. Tickeron A.I. detected that in 86 of 92 cases where TXG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.
NASDAQ:TXGLong
by AlTorress
Cup and HandleSupport noted at 113ish Strong support at 111ish Large player interest noted with high effective volume No rising wedges noted Hammer on monthly but at a high. .Hoping for pull back closer to support Not a recommendation 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. Its company offers chromium instruments, enzymes, microfluidic chips, slides, reagents, and other consumable products. The company's single cell solution runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell ATAC for measuring epigenetics, including the physical organization of DNA; single cell CNV for measuring cellular heterogeneity through DNA changes, such as copy number variation; and visium spatial gene expression solution that measures the spatial gene expression patterns across a tissue sample. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10X Genomics, Inc. in November 2014. 10x Genomics, Inc. was founded in 2012 and is headquartered in Pleasanton, California.
NASDAQ:TXGLong
by lauralea